FDA Approves Controversial Cholesterol-Fighting Drug Despite Criticism From Cardiologists

The FDA approved the cholesterol-fighting drug Liptruzet Friday, despite criticism from cardiologists that studies have not shown the drug to be effective in lowering patients' chances of developing heart disease.